HTG Molecular Diagnostics, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 73 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-02-25: Reporting owner LYTTON LAURENCE W; Form 4; Security Series A Convertible Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2020-02-25: Reporting owner LYTTON LAURENCE W; Form 4; Security Series A Convertible Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-02-25 | LYTTON LAURENCE W 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +193 193 owned after | $59.00 | 2020-02-27 | |
| 2020-02-25 | LYTTON LAURENCE W 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +96 96 owned after | $59.00 | 2020-02-27 |